<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rhesus monkeys frequently develop <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> followed by type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> when allowed free access to chow </plain></SENT>
<SENT sid="1" pm="."><plain>This <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is partly due to defective <z:chebi fb="105" ids="17234">glucose</z:chebi> transport into skeletal muscle </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined signaling factors required for insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> transport in muscle biopsies taken during euglycemic-hyperinsulinemic clamps in nondiabetic, <z:mp ids='MP_0001261'>obese</z:mp> <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e>, and diabetic monkeys </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">Insulin increased</z:e> activities of insulin receptor substrate (IRS)-1-dependent phosphatidylinositol (PI) 3-kinase and its downstream effectors, atypical protein kinase Cs (aPKCs) (zeta/lambda/iota) and protein kinase B (PKB) in muscles of nondiabetic monkeys </plain></SENT>
<SENT sid="4" pm="."><plain>Insulin-induced increases in <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal and aPKC activity diminished progressively in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and diabetic monkeys </plain></SENT>
<SENT sid="5" pm="."><plain>Decreases in aPKC activation appeared to be at least partly due to diminished activation of IRS-1-dependent PI 3-kinase, but direct activation of aPKCs by the PI 3-kinase <z:chebi fb="23" ids="18059">lipid</z:chebi> product PI-3,4,5-(PO(4))(3) was also diminished </plain></SENT>
<SENT sid="6" pm="."><plain>In conjunction with aPKCs, PKB activation was diminished in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> muscle but, differently from aPKCs, seemed to partially improve in diabetic muscle </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, calorie restriction and avoidance of <z:hpo ids='HP_0001513'>obesity</z:hpo> largely prevented development of defects in <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal and aPKC activation </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings suggest that defective activation of aPKCs contributes importantly to <z:hpo ids='HP_0001513'>obesity</z:hpo>-dependent development of skeletal muscle <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and type 2 diabetic monkeys </plain></SENT>
</text></document>